Fever Labs, Inc.
Other Technology · New York, New York
Fever Labs, Inc. is a other technology company based in New York, New York, incorporated in 2011. It has raised at least $447.2 million across 8 known rounds, of which $347.2 million was reported to the SEC on 7 Form D filings, most recently in 2023.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2025-06-04 | Growth | $100.0M | $218.1M | Round pagesource ↗ | |
| 2023-01-25 | — | $68.5M | $118.1M | SEC Form D | |
| 2019-07-08 | — | $23.9M | $49.6M | SEC Form D | |
| 2018-02-20 | —+1 amd | $19.6M | $25.7M | SEC Form D | |
| 2015-11-16 | — | $6.0M | $6.0M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Firms whose own published portfolio pages list this company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.